Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited (Mainboard IPO, NSE symbol SYMBIOTEC) listed on NSE on 1 Sep 2026. Issue price ₹988, lot size 15 shares (minimum investment ₹14,820). Subscribed 71.26x overall (QIB 172.03x, NII 73.63x, retail 12.96x) as of 27 Aug 2026, 19:00 IST. It opened at ₹988.00, 0.0% against the issue price, and last closed at ₹1,598.60 (20 Nov 2026).
Key facts
- Issue price
- ₹988
- Lot size
- 15 shares
- Minimum investment
- ₹14,820
- Issue size
- ₹150 Cr
- Subscribed
- 71.26x
- Listing
- 1 Sep
IPO dates
| Step | Date |
|---|---|
| Bidding opens | Mon, 24 Aug 2026 |
| Bidding closes | Thu, 27 Aug 2026 |
| Listing on NSE | Tue, 1 Sep 2026 |
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail minimum | 1 | 15 | ₹14,820 |
| Retail maximum (up to ₹2 lakh) | 13 | 195 | ₹1,92,660 |
| Small NII minimum (above ₹2 lakh) | 14 | 210 | ₹2,07,480 |
Subscription status
27 Aug 2026, 19:00 IST| Category | Shares bid for | Subscribed |
|---|---|---|
| QIB (institutions) | 64,33,59,195 | 172.03x |
| NII (non-institutional) | 20,65,35,120 | 73.63x |
| NII above ₹10 lakh | 15,50,46,495 | 82.92x |
| NII ₹2-10 lakh | 5,14,88,625 | 55.07x |
| Retail | 8,48,10,330 | 12.96x |
| Employees | 5,45,055 | 15.41x |
| Total | 93,52,49,700 | 71.26x |
Listing performance
NSE · 20 Nov 2026- Issue price
- ₹988
- Listing open, 1 Sep
- ₹988.00 0.0%
- Listing day close
- ₹1,097.70 +11.1%
- Last close, 20 Nov
- ₹1,598.60 +61.8%
Issue details
- Company
- Symbiotec Pharmalab Limited
- NSE symbol
- SYMBIOTEC
- ISIN
- INE899I01028
- Issue type
- Mainboard IPO · Book Building
- Face value
- ₹2 a share
- Shares offered
- 1,31,24,929 (excluding anchor investors)
- Issue size
- Initial Public Offer of Fresh Issue of Aggregating Up to Rs. 1,500 million and Offer for sale up to Rs. 16,070 million (Including Eligible Employees Reservation Portion of Aggregating up to Rs. 30 million and Anchor portion of 53,25,909 Equity shares)
- Lead managers
- JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited
- Registrar
- MUFG Intime India Private Limited
- Offer document
- Red herring prospectus (NSE)
Frequently asked questions
What is the Symbiotec Pharmalab IPO price band?
₹938 to ₹988 per share; the final issue price is ₹988.
What is the Symbiotec Pharmalab IPO lot size?
15 shares. At ₹988 a share the minimum application is ₹14,820.
When does the Symbiotec Pharmalab IPO open and close?
It opens on 24 Aug 2026 and closes on 27 Aug 2026.
What is the Symbiotec Pharmalab IPO subscription status?
71.26x overall as of 27 Aug 2026, 19:00 IST (QIB (institutions): 172.03x; NII (non-institutional): 73.63x; NII above ₹10 lakh: 82.92x; NII ₹2-10 lakh: 55.07x; Retail: 12.96x; Employees: 15.41x).
When did Symbiotec Pharmalab list?
On 1 Sep 2026, on NSE.
What was the Symbiotec Pharmalab listing gain?
It opened at ₹988.00 on 1 Sep 2026, 0.0% against the issue price of ₹988, and closed the day at ₹1,097.70 (+11.1%).
Who is the registrar of the Symbiotec Pharmalab IPO?
MUFG Intime India Private Limited. The registrar finalises the allotment; its website has the allotment status by PAN or application number.
Facts from NSE's public IPO data, for information only: not investment advice or a recommendation to apply, buy or sell. Check the offer document (RHP) before applying.
Research the shares once they list. Price charts, results, shareholding and screeners for every NSE share, with alerts when a stock you follow moves.
Start free trial

